For in vitro diagnostic use. Others Elecsys PlGF IVD Elecsys® PlGF CPS_000498 05144671190 PLGF Elecsys cobas e 100 Elecsys PlGF 04015630925391 Reagents, kits 100 tests cobas e 411/601/602 true 07027648190 PLGF Elecsys E2G 100 Elecsys PlGF 04015630940479 Reagents, kits 100 tests cobas e 402/801 true 05144671500 Elecsys PlGF en 12 FF00000004837C0E FF000000004A5E0E 05144671190 618 cobas e 411 2325 cobas e 602 619 cobas e 601 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useImmunoassay for the in vitro quantitative determination of placental growth factor (PlGF) in human serum.The Elecsys PlGF assay is used in combination with the Elecsys sFlt‑1 assay to determine the sFlt‑1/PlGF ratio. The sFlt‑1/PlGF ratio is intended for use as an aid in the diagnosis of preeclampsia in conjunction with other diagnostic and clinical information.In addition the sFlt‑1/PlGF ratio is intended for use as an aid in short-term prediction of preeclampsia (rule-out and rule-in) in pregnant women with suspicion of preeclampsia in conjunction with other diagnostic and clinical information.This assay is intended for the use as one component, in combination with other parameters, to evaluate the risk of early-onset preeclampsia during the first trimester of pregnancy.The electrochemiluminescence immunoassay “ECLIA” is intended for use on Elecsys and cobas e immunoassay analyzers. en 07027648500 Elecsys PlGF en 6 FF000000050D5B0E FF00000004EB2B0E 07027648190 2497 cobas e 801 9494 cobas e 402 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useImmunoassay for the in vitro quantitative determination of placental growth factor (PlGF) in human serum.The Elecsys PlGF assay is used in combination with the Elecsys sFlt‑1 assay to determine the sFlt‑1/PlGF ratio. The sFlt‑1/PlGF ratio is intended for use as an aid in the diagnosis of preeclampsia in conjunction with other diagnostic and clinical information.In addition the sFlt‑1/PlGF ratio is intended for use as an aid in short-term prediction of preeclampsia (rule-out and rule-in) in pregnant women with suspicion of preeclampsia in conjunction with other diagnostic and clinical information.This assay is intended for the use as one component, in combination with other parameters, to evaluate the risk of early-onset preeclampsia during the first trimester of pregnancy.The electrochemiluminescence immunoassay “ECLIA” is intended for use on cobas e immunoassay analyzers. en